Fanconi Anemia Pathway Deficiency Drives Copy Number Variation in Squamous Cell Carcinomas

Fanconi anemia (FA), a model syndrome of genome instability, is caused by a deficiency in DNA interstrand crosslink (ICL) repair resulting in chromosome breakage1–3. The FA repair pathway comprises at least 22 FANC proteins including BRCA1 and BRCA24–6, and protects against carcinogenic endogenous and exogenous aldehydes7–10. Individuals with FA are hundreds to thousands-fold more likely to develop head and neck (HNSCC), esophageal and anogenital squamous cell carcinomas (SCCs) with a median onset age of 31 years11. The aggressive nature of these tumors and poor patient tolerance of platinum and radiation-based therapy have been associated with short survival in FA11–16. Molecular studies of SCCs from individuals with FA (FA SCCs) have been limited, and it is unclear how they relate to sporadic HNSCCs primarily driven by tobacco and alcohol exposure or human papillomavirus (HPV) infection17. Here, by sequencing FA SCCs, we demonstrate that the primary genomic signature of FA-deficiency is the presence of a high number of structural variants (SVs). SVs are enriched for small deletions, unbalanced translocations, and fold-back inversions that arise in the context of TP53 loss. The SV breakpoints preferentially localize to early replicating regions, common fragile sites, tandem repeats, and SINE elements. SVs are often connected forming complex rearrangements. Resultant genomic instability underlies elevated copy number alteration (CNA) rates of key HNSCC-associated genes, including PIK3CA, MYC, CSMD1, PTPRD, YAP1, MXD4, and EGFR. In contrast to sporadic HNSCC, we find no evidence of HPV infection in FA HNSCC, although positive cases were identified in gynecologic tumors. A murine allograft model of FA pathway-deficient SCC was enriched in SVs, exhibited dramatic tumor growth advantage, more rapid epithelial-to-mesenchymal transition (EMT), and enhanced autonomous inflammatory signaling when compared to an FA pathway-proficient model. In light of the protective role of the FA pathway against SV formation uncovered here, and recent findings of FA pathway insufficiency in the setting of increased formaldehyde load resulting in hematopoietic stem cell failure and carcinogenesis18–20, we propose that high copy-number instability in sporadic HNSCC may result from functional overload of the FA pathway by endogenous and exogenous DNA crosslinking agents. Our work lays the foundation for improved FA patient treatment and demonstrates that FA SCC is a powerful model to study tumorigenesis resulting from DNA crosslinking damage.

[1]  A. Smogorzewska,et al.  Endogenous formaldehyde destroys blood stem cells. , 2021, Blood.

[2]  Liwu Fu,et al.  The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment , 2021, Acta pharmaceutica Sinica. B.

[3]  Inigo Martincorena,et al.  Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing , 2020, Nature Protocols.

[4]  M. Nagasaki,et al.  Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome , 2020, Science advances.

[5]  C. R. Leemans,et al.  Head and neck squamous cell carcinoma , 2020, Nature Reviews Disease Primers.

[6]  S. Chandrasekharappa,et al.  Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic FANCA variant , 2020, Cold Spring Harbor molecular case studies.

[7]  Nicola K. Wilson,et al.  Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans , 2020, Molecular cell.

[8]  P. Ceppi,et al.  Targeting EMT in Cancer with Repurposed Metabolic Inhibitors. , 2020, Trends in cancer.

[9]  J. Grandis,et al.  Alterations and molecular targeting of the GSK-3 regulator, PI3K, in head and neck cancer. , 2020, Biochimica et biophysica acta. Molecular cell research.

[10]  Alfred Böcking,et al.  Diagnostic accuracy of brush biopsy–based cytology for the early detection of oral cancer and precursors in Fanconi anemia , 2020, Cancer cytopathology.

[11]  Nuno A. Fonseca,et al.  Patterns of somatic structural variation in human cancer genomes , 2020, Nature.

[12]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[13]  Icgc,et al.  Pan-cancer analysis of whole genomes , 2017, bioRxiv.

[14]  Mihai I Truica,et al.  Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy. , 2019, Cancer cell.

[15]  H. Rugo,et al.  Alpelisib for PIK3CA‐Mutated, Hormone Receptor–Positive Advanced Breast Cancer , 2019, The New England journal of medicine.

[16]  N. Lee,et al.  Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature , 2019, Head & neck.

[17]  Simion I. Chiosea,et al.  Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer , 2019, The Journal of experimental medicine.

[18]  T. Crawford,et al.  Chromosome instability syndromes , 2018, Nature Reviews Disease Primers.

[19]  M. Stratton,et al.  The mutational landscape of normal human endometrial epithelium , 2018, bioRxiv.

[20]  Yassen Assenov,et al.  Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.

[21]  Véronique Geoffroy,et al.  AnnotSV: an integrated tool for structural variations annotation , 2018, Bioinform..

[22]  G. Turcatti,et al.  Targeting STING with covalent small-molecule inhibitors , 2018, Nature.

[23]  David T. Long,et al.  The evolving role of DNA inter-strand crosslinks in chemotherapy. , 2018, Current opinion in pharmacology (Print).

[24]  Joshua M. Stuart,et al.  Resource Genomic , Pathway Networ k , and Immunologic Features Distinguishing Squamous Carcinomas Graphical , 2018 .

[25]  M. Stratton,et al.  Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells , 2018, Nature.

[26]  Samuel F. Bakhoum,et al.  Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.

[27]  Edison T. Liu,et al.  Mechanism of tandem duplication formation in BRCA1 mutant cells , 2017, Nature.

[28]  P. Rosenberg,et al.  Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up , 2017, Haematologica.

[29]  Michael C. Schatz,et al.  Accurate detection of complex structural variations using single molecule sequencing , 2017, Nature Methods.

[30]  Martin A. M. Reijns,et al.  cGAS surveillance of micronuclei links genome instability to innate immunity , 2017, Nature.

[31]  Dennis E Discher,et al.  Mitotic progression following DNA damage enables pattern recognition within micronuclei , 2017, Nature.

[32]  Rob Patro,et al.  Salmon provides fast and bias-aware quantification of transcript expression , 2017, Nature Methods.

[33]  Benjamin J. Raphael,et al.  Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.

[34]  Qiang Sun,et al.  The Papillomavirus Episteme: a major update to the papillomavirus sequence database , 2016, Nucleic Acids Res..

[35]  Paul Flicek,et al.  The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data , 2016, Nucleic Acids Res..

[36]  Andrew Menzies,et al.  ascatNgs: Identifying Somatically Acquired Copy‐Number Alterations from Whole‐Genome Sequencing Data , 2016, Current protocols in bioinformatics.

[37]  Allison P. Heath,et al.  Toward a Shared Vision for Cancer Genomic Data. , 2016, The New England journal of medicine.

[38]  A. D’Andrea,et al.  The Fanconi anaemia pathway: new players and new functions , 2016, Nature Reviews Molecular Cell Biology.

[39]  David C. Jones,et al.  Landscape of somatic mutations in 560 breast cancer whole genome sequences , 2016, Nature.

[40]  Jeffrey H. Chuang,et al.  The tandem duplicator phenotype as a distinct genomic configuration in cancer , 2016, Proceedings of the National Academy of Sciences.

[41]  Eric Talevich,et al.  CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing , 2016, PLoS Comput. Biol..

[42]  J. Radford Nivolumab for recurrent squamous-cell carcinoma of the head and neck , 2016, BDJ.

[43]  M. Robinson,et al.  Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. , 2015, F1000Research.

[44]  K. J. Patel,et al.  Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen , 2015, Molecular cell.

[45]  J. Grandis,et al.  Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer , 2015, PloS one.

[46]  Elizabeth E. Hoskins,et al.  Oral Human Papillomavirus Is Common in Individuals with Fanconi Anemia , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[47]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[48]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[49]  A. Smogorzewska,et al.  SnapShot: Fanconi Anemia and Associated Proteins , 2015, Cell.

[50]  Benjamin J. Raphael,et al.  Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data , 2014, Bioinform..

[51]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[52]  Lars Feuk,et al.  The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..

[53]  K. Cimprich,et al.  Causes and consequences of replication stress , 2013, Nature Cell Biology.

[54]  S. Miyano,et al.  Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. , 2013, Blood.

[55]  M. Schiffman,et al.  Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: A search for human papillomavirus , 2013, International journal of cancer.

[56]  M. Rowicka,et al.  Nucleotide-resolution DNA double-strand breaks mapping by next-generation sequencing , 2013, Nature Methods.

[57]  Heng Li Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[58]  L. Staudt,et al.  Identification of Early Replicating Fragile Sites that Contribute to Genome Instability , 2013, Cell.

[59]  Molly C. Kottemann,et al.  Fanconi anaemia and the repair of Watson and Crick DNA crosslinks , 2013, Nature.

[60]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[61]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[62]  Paz Polak,et al.  Differential relationship of DNA replication timing to different forms of human mutation and variation. , 2012, American journal of human genetics.

[63]  Gabor T. Marth,et al.  Haplotype-based variant detection from short-read sequencing , 2012, 1207.3907.

[64]  Francesca Chiaromonte,et al.  A genome-wide analysis of common fragile sites: What features determine chromosomal instability in the human genome? , 2012, Genome research.

[65]  Elizabeth E. Hoskins,et al.  The Fanconi Anemia Pathway Limits Human Papillomavirus Replication , 2012, Journal of Virology.

[66]  D. Kutler,et al.  Postoperative clinical radiosensitivity in patients with fanconi anemia and head and neck squamous cell carcinoma. , 2011, Archives of otolaryngology--head & neck surgery.

[67]  C. Cole,et al.  COSMIC: the catalogue of somatic mutations in cancer , 2011, Genome Biology.

[68]  K. J. Patel,et al.  Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice , 2011, Nature.

[69]  E. Fuchs,et al.  Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling , 2011, Proceedings of the National Academy of Sciences.

[70]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[71]  P. Deloukas,et al.  Signatures of mutation and selection in the cancer genome , 2010, Nature.

[72]  E. Fuchs,et al.  Isolation and culture of epithelial stem cells. , 2009, Methods in molecular biology.

[73]  C. R. Leemans,et al.  Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. , 2008, Journal of the National Cancer Institute.

[74]  Bhuvanesh Singh,et al.  Downregulation of Fanconi Anemia Genes in Sporadic Head and Neck Squamous Cell Carcinoma , 2007, ORL.

[75]  Christopher U. Jones,et al.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.

[76]  A. D’Andrea,et al.  The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. , 2005, Human molecular genetics.

[77]  Mei Liu,et al.  Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival , 2004, Oncogene.

[78]  A. Auerbach,et al.  First announcement of the Fanconi anemia International Registry , 1982, Human Genetics.

[79]  J. Satagopan,et al.  Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. , 2004, Journal of the National Cancer Institute.

[80]  Marianne Berwick,et al.  A 20-year perspective on the International Fanconi Anemia Registry (IFAR). , 2003, Blood.

[81]  J. Shah,et al.  High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. , 2003, Archives of otolaryngology--head & neck surgery.

[82]  R. Benz,et al.  Sensitivity to five mutagens in Fanconi's anemia as measured by the micronucleus method. , 1978, Cancer research.

[83]  A. Auerbach,et al.  Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens , 1976, Nature.

[84]  M. Sasaki,et al.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. , 1973, Cancer research.